Thursday, February 19

Healthcare

Travere gains on full FDA approval for kidney drug Filspari

09/07/20241 Min Read

approval drug FDA Filspari full gains kidney Travere

Previous ArticleGSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD

Next Article Fanhua and Shanghai Biotecan Pharmaceuticals enters into cooperation agreement